Etanercept in the treatment of a patient with acute generalized exanthematous pustulosis/toxic epidermal necrolysis: definition of a new model based on translational research

Int J Dermatol. 2009 Aug;48(8):913-4. doi: 10.1111/j.1365-4632.2008.04020.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Amoxicillin-Potassium Clavulanate Combination / adverse effects*
  • Anti-Bacterial Agents / adverse effects
  • Etanercept
  • Exanthema / drug therapy*
  • Female
  • Humans
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / therapeutic use*
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use*
  • Stevens-Johnson Syndrome / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Amoxicillin-Potassium Clavulanate Combination
  • Etanercept